TKNO
Alpha Teknova, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$6.92
−4.42%Aug 20, 2026, 02:02 UTC
Alpha Teknova reported record second-quarter revenue and raised its full-year outlook, citing improved biopharma funding and life-science end markets.
Source:Aug 5, 2026, 20:01 UTC
Alpha Teknova reported second quarter 2026 financial results with total revenue of $12.2 million, up 18% year-over-year.
Aug 5, 2026, 12:59 UTC
Alpha Teknova, Inc. launched Build-Tek, an AI-powered custom order configurator that allows customers to design complex custom products and submit a request for quote in minutes.
Jun 1, 2026, 00:00 UTC
Brett Robertson was elected as a Class II director of Alpha Teknova, Inc., effective June 1, 2026.
Jun 1, 2026, 00:00 UTC
J. Matthew Mackowski was elected as a Class II director of Alpha Teknova, Inc., effective June 1, 2026.
Jun 1, 2026, 00:00 UTC
Irene Davis departed as a member of the Board of Directors and the Nominating and Corporate Governance Committee of Alpha Teknova, Inc.